Laurus Labs FY26: Revenue up 23%, PAT more than doubles; Rs 1.20 interim dividend

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹1106.70

prior close

₹1102.05

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.0%+0.9% vs market

Pharmaceuticals peers, median of 161sector-0.3%+0.3% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Midcap 150 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-0.1

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0-1.0+0.9-0.3+0.3

Next day

+5.3-0.3+5.5+0.3+5.0

+5.1-0.1+5.2+0.5+4.6

+6.6+1.5+5.1+1.8+4.8

+8.8+2.7+6.1+3.1+5.6

+10.7+2.5+8.2+3.6+7.1

+14.9-1.1+16.1+1.6+13.4

15d

+21.1+1.3+19.8+1.7+19.4

+25.3+0.2+25.1+2.5+22.8

+37.0+2.5+34.5+5.7+31.3

+61.0+3.7+57.3+7.8+53.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laurus Labs reported FY26 consolidated revenue of Rs 6,812.90 cr, up ~23% YoY from Rs 5,553.96 cr. Net profit more than doubled to Rs 292.03 cr vs Rs 129.88 cr. Q4 revenue rose 5% to Rs 1,811.57 cr; Q4 PAT was Rs 281.91 cr. Operating cash flow was strong at Rs 1,623.50 cr. Deloitte issued an unmodified opinion. Board declared 2nd interim dividend of Rs 1.20/share (60%), record date May 8, 2026. 21st AGM set for July 2, 2026.

Likely market impact

Strong revenue and profit growth with robust cash generation plus interim dividend should be viewed positively by shareholders.